Identification of Novel Biphenyl Carboxylic Acid Derivatives as Novel Antiresorptive Agents that Do Not Impair Parathyroid Hormone-Induced Bone FormationIDRIS, Aymen I; GREIG, Iain R; BASSONGA-LANDAO, Euphemie et al.Endocrinology (Philadelphia). 2009, Vol 150, Num 1, pp 5-13, issn 0013-7227, 9 p.Article

Risedronate on Two Consecutive Days per MonthFRAMPTON, James E.Drugs & aging. 2009, Vol 26, Num 4, pp 355-362, issn 1170-229X, 8 p.Article

Are Cathepsin K Inhibitors Just Another Class of Anti-Resorptives?CHAMBERS, T. J; TOBIAS, J. H.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 11, pp 4329-4331, issn 0021-972X, 3 p.Article

Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In VivoOTTEWELL, Penelope D; NING WANG; BROWN, Hannah K et al.Clinical cancer research (Print). 2014, Vol 20, Num 11, pp 2922-2932, issn 1078-0432, 11 p.Article

Clinical Efficacy of 1 % Alendronate Gel in Adjunct to Mechanotherapy in the Treatment of Aggressive Periodontitis: A Randomized Controlled Clinical TrialSHARMA, Anuj; PRADEEP, A. R.Journal of periodontology (1970). 2012, Vol 83, Num 1, pp 19-26, issn 0022-3492, 8 p.Article

Increased Numbers of Nonattached Osteoclasts After Long-Term Zoledronic Acid Therapy in MiceKUROSHIMA, Shinichiro; GO, Virginia-Arlene A; YAMASHITA, Junro et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 1, pp 17-28, issn 0013-7227, 12 p.Article

Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosisSCHAUDINN, Christoph; GORUR, Amita; WEBSTER, Paul et al.Oral surgery, oral medicine, oral pathology and oral radiology (Print). 2012, Vol 114, Num 4, pp 480-486, issn 2212-4403, 7 p.Article

Current and future treatment options in osteoporosisBREWER, Linda; WILLIAMS, David; MOORE, Alan et al.European journal of clinical pharmacology. 2011, Vol 67, Num 4, pp 321-331, issn 0031-6970, 11 p.Article

Ion Chromatography Method for Determination of Risedronate in Pharmaceutical PreparationsKANMATAREDDY, Avanthi; DE BORBA, Brian; ROHRER, Jeffrey et al.LC GC North America. 2011, Vol 29, Num SEP, issn 1527-5949, p. 44, SUPArticle

The Effect of Long-term Alendronate Treatment on Cortical Thickness of the Proximal FemurKOH, Joyce S. B; NG, Alvin C. M; MENG AI PNG et al.Clinical orthopaedics and related research. 2011, Vol 469, Num 12, pp 3509-3510, issn 0009-921X, 2 p.Article

Bone Morphology in Response to Alendronate as Seen by High-Resolution Computed Tomography: Through a Glass DarklySEEMAN, Ego.Journal of bone and mineral research (Print). 2010, Vol 25, Num 12, pp 2277-2281, issn 0884-0431, 5 p.Article

Bisphosphonates et myélome multiple : utilisation clinique = Bisphophonates in multiple myelomaMOREAU, Philippe.Hématologie (Montrouge). 2008, Vol 14, Num 3, pp 239-243, issn 1264-7527, 5 p.Article

Acute Charcot Arthropathy Successfully Treated With Pamidronate : Long-Term Follow-upNAQVI, Asghar; CUCHACOVICH, Raquel; SAKETKOO, Lesley et al.The American journal of the medical sciences. 2008, Vol 335, Num 2, pp 145-148, issn 0002-9629, 4 p.Article

Biodistribution and Plasma Protein Binding of Zoledronic AcidMARKUS WEISS, H; PFAAR, Ulrike; SCHWEITZER, Alain et al.Drug metabolism and disposition. 2008, Vol 36, Num 10, pp 2043-2049, issn 0090-9556, 7 p.Article

The use of eidronate disodium in the prevention of heterotopic ossification in burn patientsSHAFER, David M; BAY, Curt; CARUSO, Daniel M et al.Burns. 2008, Vol 34, Num 3, pp 355-360, issn 0305-4179, 6 p.Article

Tooth Extraction Socket Healing in Pediatric Patients Treated with Intravenous PamidronateCHAHINE, Carol; CHEUNG, Moira S; HEAD, Timothy W et al.The Journal of pediatrics. 2008, Vol 153, Num 5, pp 719-720, issn 0022-3476, 2 p.Article

Waldeström macroglobulinaemia relapsing with focal bone disease and achieving major response with single-agent zoledronic acidBAKHOUS, Aziz; HONGYUN ZHU; WAHEED, Sarah et al.British journal of haematology. 2013, Vol 163, Num 3, issn 0007-1048, p. 293Article

The Effect of Long-term Alendronate Treatment on Cortical Thickness of the Proximal FemurUNNANUNTANA, Aasis; ASHFAQ, Kashif; TON, Quang V et al.Clinical orthopaedics and related research. 2012, Vol 470, Num 1, pp 291-298, issn 0009-921X, 8 p.Article

Local application of zoledronate for maximum anchorage during space closureAJ ORTEGA, Adam J; CAMPBELL, Phillip M; HINTON, Robert et al.American journal of orthodontics and dentofacial orthopedics. 2012, Vol 142, Num 6, pp 780-791, issn 0889-5406, 12 p.Article

Liposomal alendronate for the treatment of restenosisGUTMAN, Dikla; GOLOMB, Gershon.Journal of controlled release. 2012, Vol 161, Num 2, pp 619-627, issn 0168-3659, 9 p.Article

En bref - Risédronate à libération retardée = In brief: delayed-release risedronate (Atelvia)The Medical letter on drugs and therapeutics (Edition française). 2011, Vol 33, Num 8, issn 0253-8512, p. 29Article

Effect of Zoledronate on Oral Wound Healing in RatsYAMASHITA, Junro; KOI, Kiyono; YANG, Dong-Ye et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1405-1414, issn 1078-0432, 10 p.Article

Effects of Intravenous Zoledronic Acid Plus Subcutaneous Teriparatide [rhPTH(1―34)] in Postmenopausal OsteoporosisCOSMAN, Felicia; FINK ERIKSEN, Erik; BUCCI-RECHTWEG, Christina et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 3, pp 503-511, issn 0884-0431, 9 p.Article

Nanotechnologies to use zoledronic acid as a potent antitumoral agentSALZANO, G; MARRA, M; LEONETTI, C et al.Journal of drug delivery science and technology. 2011, Vol 21, Num 3, pp 283-284, issn 1773-2247, 2 p.Article

Jaw bone changes in rats after treatment with zoledronate and pamidronateSENEL, Figen Cizmeci; DUMAN, Mine Kadioglu; MUCI, Efnan et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2010, Vol 109, Num 3, pp 385-391, issn 1079-2104, 7 p.Article